Clinical Trial Update: Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous bone marrow transplantation using a preparative regimen of busulfan/fractionated total body irradiation and etoposide (VP16)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• Etoposide (Etoposide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2023-03-21